NPC1 and nasopharyngeal carcinoma: A recent study investigated the effects of supplementing Npc1-/- mice with the antioxidant N-acetylcysteine beginning at 4 or 6 weeks of age, and noted a modest reduction in oxidative stress markers and a slight improvement in certain aspects of the NPC disease phenotype in the N-acetylcysteine-treated animals [98].